Illumina, Inc. (NASDAQ:ILMN) today announced that it has begun shipping its new HumanOmni2.5-Quad DNA Analysis BeadChip (Omni2.5). This microarray contains millions of newly discovered genome-wide ...
Illumina began taking orders for a new whole-genome expression product for rat that analyzes 12 samples in parallel on a single BeadChip. Content for the new RatRef-12 Expression BeadChip is derived ...
For most researchers DNA microarrays are synonymous with high-throughput gene expression analysis. But they also are invaluable genotyping tools. Now that the International HapMap Project (see article ...
Illumina, Inc. (NASDAQ:ILMN) today announced the HumanOmniExpress BeadChip (OmniExpress), the newest addition to the Omni family of microarrays for genome-wide association studies (GWAS). Designed as ...
Illumina, Inc. has announced that it is collaborating with the Wellcome Trust Sanger Institute (WTSI) and the Wellcome Trust Case-Control Consortium (WT-CCC) on the design of a custom Sentrix® ...
Microarray-based transcription profiling studies have provided important advances in our understanding of differential gene expression in heterogeneous cell populations—for example, in cancerous ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback